Overview
Neuros Life Sciences develops small-molecule therapeutics targeting neuroinflammation pathways to treat Alzheimer's disease and related dementias.
More in Neuropharmaceuticals
Latest industry news
Neuralink Pretrained on 50,000 Hours of Unlabeled Brain Data — and the Implications Are Enormous
2026-10-03 · Research
BlueWind Medical Wins Category I CPT Code for Subfascial Tibial Neuromodulation
2026-10-02 · Policy
Neurable One Brings Brain-Computer Interface Technology to Consumer Wireless Headphones
2026-10-01 · Product
ReVision Implant Secures €4 Million to Push Visual Neuroprosthetics Forward
2026-09-30 · Funding
Company details
Category
💊 Neuropharmaceuticals
Location
San Diego, CA
Funding
Series A — $42M
Website
neuroslifesciences.comListed
2026-08-03
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →